Live Verdure Ltd (ASX:LV1) Expands Stake in Decidr.ai
Live Verdure Ltd (ASX:LV1) increases its stake in Decidr.ai to 51% with a $13.2 million acquisition to expand AI-driven solutions.
Category: Healthcare
LTR Pharma Limited (ASX:LTP) Responds to ASX Queries
LTR Pharma Limited addresses ASX queries regarding its cleansing notice and an access agreement with Men’s Health Downunder.
Imricor Medical Systems, Inc. (ASX: IMR) Expands into Middle East
Imricor Medical Systems (ASX: IMR) announces its first sale in Qatar, marking a pivotal expansion in the Middle East market.
Pro Medicus Limited (ASX: PME) Secures $15M Deal with Duke University
Pro Medicus Limited (ASX: PME) announces a $15M contract with Duke University for Visage 7 Open Archive, enhancing operational capabilities.
Dimerix Limited (ASX: DXB) Achieves Key Milestone in DMX-200 Phase 3 Trial
Dimerix Limited (ASX: DXB) announces the recruitment of 144 patients in its DMX-200 Phase 3 trial, paving the way for potential accelerated regulatory approval.
Mayfield Childcare Limited (ASX:MFD) – Securities Suspension
Mayfield Childcare Limited (ASX:MFD) has requested a voluntary suspension of trading pending a transaction announcement.
Osteopore Limited (ASX:OSX) Secures A$20m with Convertible Notes
Osteopore Limited has secured A$20 million through a subscription agreement to issue redeemable convertible notes.
Echo IQ (ASX:EIQ) Requests FDA Meeting for Heart Failure Solution
Echo IQ (ASX:EIQ) requests a meeting with the FDA for its heart failure solution, EchoSolv HF, following successful study outcomes.
M8 Sustainable Ltd (ASX:M8S) Releases Quarterly Activities Report
M8 Sustainable Ltd (ASX:M8S) reports operational updates on its metals shredding facility and financial performance in its latest quarterly report.
Rhythm Biosciences Ltd (ASX: RHY) Completes Genetype Acquisition
Rhythm Biosciences Ltd completes the acquisition of Genetype assets, enhancing its cancer diagnostics portfolio.